Related Experiment Video
Updated: Jun 3, 2026
02:08
Surgical Bone Implantation Technique for Rat Tibia Models of Diabetes and Osteoporosis
Published on: July 5, 2024
Review: The diabetic bone: a cellular and molecular perspective
Robert Blakytny1, Maximilian Spraul, Edward B Jude
1University of Ulm, Ulm, Germany.
The International Journal of Lower Extremity Wounds
|March 30, 2011
Summary
Diabetes significantly impacts bone health, increasing fracture risk and delaying healing in both type 1 and type 2 diabetes. Understanding cellular and molecular changes is key to developing targeted interventions for diabetic bone complications.
Area of Science:
- Endocrinology
- Orthopedics
- Cellular Biology
Background:
- Diabetes mellitus is a global health concern with increasing prevalence.
- Diabetic complications significantly impact bone health, leading to increased fracture risk and delayed healing.
- Both type 1 and type 2 diabetes affect bone quality, irrespective of bone mass changes.
Purpose of the Study:
- To investigate the cellular and molecular mechanisms underlying bone changes in diabetes.
- To understand the impact of diabetes on fracture healing processes.
- To identify potential targets for therapeutic interventions to improve diabetic bone health and fracture outcomes.
Main Methods:
- Review of current literature on diabetes and bone health.
- Analysis of cellular and molecular pathways involved in bone metabolism.
- Utilizing findings from animal models of type 1 and type 2 diabetes.
Main Results:
- Diabetes, in both types, leads to poorer overall bone quality and increased fracture risk.
- Fracture healing is significantly delayed in diabetic patients, with a higher incidence of nonunion.
- Research is ongoing to elucidate the specific molecular and cellular changes in diabetic bone.
Conclusions:
- Diabetic bone disease presents a significant challenge, increasing fracture susceptibility and impairing healing.
- Further research into the molecular and cellular basis of diabetic bone complications is crucial.
- Targeted interventions based on identified mechanisms could improve bone health and fracture management in diabetic individuals.
Related Concept Videos
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
01:31Diabetic Foot Ulcer
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...